Opportunity Information: Apply for RFA RM 18 028
This National Institutes of Health (NIH) funding opportunity, titled "Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed)," supports technology development aimed at a major bottleneck in the extracellular RNA field: reliably working at the level of individual extracellular vesicles rather than bulk EV mixtures. EVs are small, membrane-bound particles released by cells into biofluids such as blood, urine, saliva, or cerebrospinal fluid. They can carry extracellular RNAs and other molecular cargo that reflect the state and identity of their source cells, and they may also influence recipient (target) cells. The FOA is built around the idea that single-EV isolation and cargo analysis would reveal EV heterogeneity that is largely hidden when researchers analyze EVs in aggregate, and that this heterogeneity is central to understanding how exRNAs act as communication signals in both normal physiology and disease.
The overarching goal is to develop and demonstrate innovative tools, technologies, and reagents that can (1) isolate and sort single EVs from complex human biofluids and (2) characterize the exRNA cargo associated with defined EV subpopulations. A key emphasis is connecting EV subtypes to their cell or tissue of origin and, ideally, to their intended target cell, so that exRNA signaling pathways can be mapped with much higher resolution. By clarifying the diversity and distribution of exRNAs across different EV subpopulations, NIH is aiming to deepen understanding of exRNA-mediated signaling and accelerate progress toward practical applications, especially improved diagnostics (for example, liquid biopsy-style assays that detect disease-relevant EV/exRNA signatures) and therapeutics (such as EV-based delivery systems or exRNA-targeted interventions).
The opportunity uses the UG3/UH3 cooperative agreement structure, which typically reflects a phased, milestone-driven approach under substantial NIH programmatic involvement. In practice, this kind of mechanism is commonly used when the sponsor wants to de-risk ambitious technology development: an initial phase supports feasibility and early proof-of-concept work (UG3), and a second phase supports further development and broader demonstration once predefined milestones are met (UH3). The FOA explicitly states "Clinical Trial Not Allowed," meaning applicants must not propose studies that meet NIH’s definition of a clinical trial; the focus is on technology and method development rather than testing interventions in human participants for health-related outcomes.
Administratively, the opportunity is listed as discretionary funding and categorized under health research, with CFDA number 93.310. The funding opportunity number is RFA-RM-18-028, and the sponsoring agency is NIH. The original closing date shown is 2018-10-23, and the posting creation date is 2018-08-06. While the listing does not provide an award ceiling or an expected number of awards in the provided fields, the intent is clearly to stimulate multiple efforts that can move the field toward robust single-EV sorting and exRNA cargo readouts.
Eligibility is broad and includes many organizational types: state, county, and local governments; special district governments; independent school districts; public and state-controlled universities; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); small businesses; and other eligible entities. The FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, non-U.S. (foreign) organizations, regional organizations, and U.S. territories or possessions. Overall, the program is structured to encourage participation across academia, industry, nonprofits, and a wide range of institutions, reflecting the interdisciplinary nature of the technical challenges in EV isolation and exRNA measurement.
In short, this FOA is a targeted push to enable the next level of resolution in exRNA biology by funding platform technologies that can isolate individual extracellular vesicles and accurately profile their RNA cargo, with the broader payoff being clearer insight into cell-to-cell communication and faster translation of exRNA/EV knowledge into diagnostics and therapeutics.Apply for RFA RM 18 028
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
- This funding opportunity was created on 2018-08-06.
- Applicants must submit their applications by 2018-10-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
Previous opportunity: CESU White Nose Syndrome Funding Proposal
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RM 18 028
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RM 18 028) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37) Apply for RFA MD 18 007 Funding Number: RFA MD 18 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) Apply for PAR 18 894 Funding Number: PAR 18 894 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) Apply for PAR 18 895 Funding Number: PAR 18 895 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required) Apply for RFA AG 19 020 Funding Number: RFA AG 19 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for RFA MH 19 240 Funding Number: RFA MH 19 240 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 899 Funding Number: PAR 18 899 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 037 Funding Number: RFA RM 18 037 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 900 Funding Number: PAR 18 900 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed) Apply for RFA CA 19 004 Funding Number: RFA CA 19 004 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 (Collab) Clinical Trial Not Allowed) Apply for PAR 18 905 Funding Number: PAR 18 905 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial Not Allowed) Apply for PAR 18 904 Funding Number: PAR 18 904 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed) Apply for RFA MD 18 011 Funding Number: RFA MD 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,300,000 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Apply for PA 18 906 Funding Number: PA 18 906 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 031 Funding Number: RFA RM 18 031 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54 Clinical Trial Optional) Apply for RFA RM 18 032 Funding Number: RFA RM 18 032 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1 Clinical Trial Optional) Apply for RFA RM 18 034 Funding Number: RFA RM 18 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24 Clinical Trial Optional) Apply for RFA RM 18 035 Funding Number: RFA RM 18 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1 Clinical Trial Optional) Apply for RFA RM 18 033 Funding Number: RFA RM 18 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sustainable Peri-urban Water and Sanitation services Apply for BAA DRC WASH 2018 Funding Number: BAA DRC WASH 2018 Agency: Democratic Republic of the Congo USAID-Kinshasa Category: Health Funding Amount: Case Dependent |
| New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed) Apply for PA 18 908 Funding Number: PA 18 908 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 18 028", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
